» Articles » PMID: 9370176

Changing Etiologies of Unexplained Adult Nephrotic Syndrome: a Comparison of Renal Biopsy Findings from 1976-1979 and 1995-1997

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 1997 Nov 25
PMID 9370176
Citations 127
Authors
Affiliations
Soon will be listed here.
Abstract

Data compiled during the 1970s and early 1980s indicated that during these periods, membranous nephropathy was the most common cause of unexplained nephrotic syndrome in adults, followed in order of frequency by minimal-change nephropathy and focal segmental glomerulosclerosis (FSGS). However, we and others recently reported an increase in the incidence of FSGS over the past two decades, and the number of cases of FSGS diagnosed by renal biopsies in these centers now exceeds the number of cases of membranous nephropathy. Nonetheless, as a substantial fraction of patients with FSGS do not have the nephrotic syndrome, it remained unclear as to what extent the relative frequencies of FSGS and other glomerulopathies as causes of the nephrotic syndrome have changed over this time. To address this concern, we reviewed data from 1,000 adult native kidney biopsies performed between January 1976 and April 1979 and from 1,000 biopsies performed between January 1995 and January 1997, identified all cases with a full-blown nephrotic syndrome of unknown etiology at the time of biopsy, and compared the relative frequencies with which specific diseases were diagnosed in these latter cases between the two time intervals. The main findings of this study were that, first, during the 1976 to 1979 period, the relative frequencies of membranous (36%) and minimal-change (23%) nephropathies and of FSGS (15%) as causes of unexplained nephrotic syndrome were similar to those observed in previous studies during the 1970s and early 1980s. In contrast, from 1995 to 1997, FSGS was the most common cause of this syndrome, accounting for 35% of cases compared with 33% for membranous nephropathy. Second, during the 1995 to 1997 period, FSGS accounted for more than 50% of cases of unexplained nephrotic syndrome in black adults and for 67% of such cases in black adults younger than 45 years. Third, although the relative frequency of nephrotic syndrome due to FSGS was two to three times higher in black than in white patients during both study periods, the frequency of FSGS increased similarly among both racial groups from the earlier to the later period. Fourth, the frequency of minimal-change nephrotic syndrome decreased from the earlier to the later study period in both black and white adults. Fifth, the relative frequency of membranoproliferative glomerulonephritis as a cause of the nephrotic syndrome declined from the 1976 to 1979 period to the 1995 to 1997 period, whereas that of immunoglobulin A nephropathy appeared to increase; the latter accounted for 14% of cases of unexplained nephrotic syndrome in white adults during the latter study period. Finally, 10% of nephrotic adults older than 44 years had AL amyloid nephropathy; none of these patients had multiple myeloma or a known paraprotein at the time of renal biopsy.

Citing Articles

Advances in Focal Segmental Glomerulosclerosis Treatment From the Perspective of the Newest Mechanisms of Podocyte Injury.

Zhu Y, Xu G Drug Des Devel Ther. 2025; 19:857-875.

PMID: 39935575 PMC: 11812565. DOI: 10.2147/DDDT.S498457.


MicroRNA Expression and Target Prediction in Children with Nephrotic Syndrome.

Charmine P, Venkatesan V, Geminiganesan S, Nammalwar B, Dandapani M Indian J Nephrol. 2025; 35(1):59-63.

PMID: 39872258 PMC: 11763170. DOI: 10.25259/ijn_47_23.


Nephrotic and Non-Nephrotic Focal Segmental Glomerulosclerosis: Clinical Characteristics, Etiology, and Columbia Classification.

Figueiredo G, Yu L, Jorge L, Woronik V, Dias C Diagnostics (Basel). 2025; 15(2).

PMID: 39857004 PMC: 11763650. DOI: 10.3390/diagnostics15020120.


Renal survival and treatment of adult patients with Primary Focal Segmental glomerulosclerosis: A historical cohort study of the National Greek Registry.

Marinaki S, Kompotiatis P, Michelakis I, Stangou M, Papagianni A, Koukoulaki M PLoS One. 2024; 19(12):e0315124.

PMID: 39693288 PMC: 11654980. DOI: 10.1371/journal.pone.0315124.


Efficacy and safety of nine immunosuppressive agents for primary focal segmental glomerulosclerosis in adults: a pairwise and network meta-analysis.

Zhu Y, Chen B, Xu G Ren Fail. 2024; 46(2):2438861.

PMID: 39663153 PMC: 11636141. DOI: 10.1080/0886022X.2024.2438861.